Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bacteriophage Cocktail for Multidrug-Resistant Bacterial Infections
ChiCTR2400091725Phase 2Not yet recruiting
- Sponsor
- Chongqing Red Cross Hospital
- Start
- Nov 2024
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of bacteriophage cocktail in urinary tract infection (UTI), pulmonary infection, Superficial Surgical Site Infection (SSI) and 1 more, sponsored by Chongqing Red Cross Hospital. Primary endpoint: Bacterial culture and identification results (phage-typing). Planned start Nov 2024; status: not yet recruiting.
02
Drugs
bacteriophage cocktail
03
Conditions
urinary tract infection (UTI)pulmonary infectionSuperficial Surgical Site Infection (SSI)bacterial disease
Beyond the preview
Go deeper on ChiCTR2400091725.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400091725.